Curevac saw the highest growth of 1.49% in patent filings and 0.66% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.56% and grants by 0.59%. GlobalData’s DataBook provides a comprehensive analysis of Curevac‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Curevac has been focused on protecting inventions in United States(US) with 11 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 43% filings and 83% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and United Kingdom(GB) patent Office are among the top ten patent offices where Curevac is filings its patents. Among the top granted patent authorities, Curevac has 83% of its grants in United States(US) and 17% in Spain(ES).
GSK and University of Pennsylvania could be the strongest competitors for Curevac
In terms of grant share, Curevac stands in fourth position among its competitors. GSK and University of Pennsylvania secured the top positions according to recent patent publication data.
Patents related to nanomedicine and rare diseases lead Curevac's portfolio
Curevac has the highest number of patents in nanomedicine followed by, rare diseases and climate change. For nanomedicine, nearly 47% of patents were filed and 30% of patents were granted in Q2 2024.
Severe acute respiratory syndrome (sars) related patents lead Curevac portfolio followed by coronaviridae infections, and coronavirus disease 2019 (covid-19)
Curevac has highest number of patents in severe acute respiratory syndrome (sars) followed by coronaviridae infections, coronavirus disease 2019 (covid-19), respiratory syncytial virus (rsv) infections, and prostate cancer. For severe acute respiratory syndrome (sars), nearly 20% of patents were filed and 23% of patents were granted in Q2 2024.
For comprehensive analysis of Curevac's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
